Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q2 2016 · 10-Q
Revenue$2.49M$2.49M+3.1% vs Q2 2015 Net Income-$2.23M-$2.23MN/M vs Q2 2015 EPS Diluted-$0.04-$0.04N/M vs Q2 2015 Gross Profit$1,664,327+29.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived-$793,402N/M Free Cash Flowderived-$793,402N/M Margins · derivedGross margin66.9%+13.5 pt vs Q2 2015
Operating margin-82.9%−0.3 pt vs Q2 2015
Net margin-89.5%−6.5 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 12, 2016 · 43 d after period end